02208nam 2200481 450 991013766880332120221010201921.0953-51-4363-8(CKB)3230000000077138(NjHacI)993230000000077138(oapen)https://directory.doabooks.org/handle/20.500.12854/61066(MiAaPQ)EBC30390164(Au-PeEL)EBL30390164(EXLCZ)99323000000007713820221010d2012 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierToxicity and Drug Testing /edited by Bill Acree1st ed.IntechOpen2012Croatia :IntechOpen,2012.1 online resource (530 pages)953-51-0004-1 Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products.ToxicologyToxicologyToxicology and Pharmaceutical ScienceToxinologyPharmacologyHealth SciencesToxicology.615.9William Acreeauth1365335Acree BillNjHacINjHaclBOOK9910137668803321Toxicity and Drug Testing3387141UNINA